### Bundle Overview

 Nomenclature (name, manufacturer) Information on the nomenclature of the drug substance should be provided. For example:

*GSRS preferred name
*Recommended International Nonproprietary Name (INN)
*Compendial name if relevant
*Chemical name(s)
*Company or laboratory code
*Other non-proprietary name(s), e.g., national name
*Chemical Abstracts Service (CAS) registry number
*IUPAC Name
*ISBT 128

For a drug product containing more than one drug substance, the information requested for part “S” should be provided in its entirety for each drug substance

Structure (name, manufacturer) NCE: The structural formula, including relative and absolute stereochemistry, the molecular formula, and the relative molecular mass should be provided.

Biotech: The schematic amino acid sequence indicating glycosylation sites or other post[1]translational modifications and relative molecular mass should be provided, as appropriate.
 

### eCTD Heading 3.2.S.1.0

<div>{%include SubstanceGeneral.svg%}</div>

### Example 3.2.S.1.0 Bundle

